Breaking Tolerance in a Mouse Model of Multiple Myeloma by Chemoimmunotherapy

This publication has 134 references indexed in Scilit:

• OX40 costimulation can abrogate Foxp3⁺ regulatory T cell‐mediated suppression of antitumor immunity
  International Journal of Cancer, 2009
• Foxp3⁺natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturation
  Proceedings of the National Academy of Sciences, 2008
• Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
  Proceedings of the National Academy of Sciences, 2008
• Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
  Cancer Immunology, Immunotherapy, 2006
• CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
  Journal of Experimental Medicine, 2006
• Foxp3 ⁺ CD25 ⁺ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage
  Proceedings of the National Academy of Sciences, 2006
• Regulatory T cells, tumour immunity and immunotherapy
  Nature Reviews Immunology, 2006
• Natural regulatory T cells in infectious disease
  Nature Immunology, 2005
• The anti-angiogenic basis of metronomic chemotherapy
  Nature Reviews Cancer, 2004
• Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
  New England Journal of Medicine, 1999